MGNX – Macrogenics Inc
MacroGenics, Inc.MGNX
$1.51Name : MacroGenics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $95,520,384.00
EPSttm : -1.21
MacroGenics, Inc.
$1.51
0.67%$0.01Float Short %
6.13
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
-0.95
EPS Last/This Y
-0.64
EPS This/Next Y
-1.07
Price
1.51
Target Price
3.4
Analyst Recom
2.38
Performance Q
1.34
Relative Volume
1.81
Beta
1.52
Ticker: MGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | MGNX | 1.71 | 0.15 | 0.00 | 4368 |
| 2025-10-21 | MGNX | 2.02 | 0.14 | 0.04 | 4522 |
| 2025-10-22 | MGNX | 1.945 | 0.13 | 0.01 | 5123 |
| 2025-10-23 | MGNX | 1.83 | 0.14 | 0.12 | 5184 |
| 2025-10-24 | MGNX | 1.83 | 0.13 | 0.61 | 5197 |
| 2025-10-27 | MGNX | 1.91 | 0.14 | 0.00 | 5318 |
| 2025-10-28 | MGNX | 1.855 | 0.14 | 0.00 | 5370 |
| 2025-10-29 | MGNX | 1.7 | 0.14 | 1.96 | 5371 |
| 2025-10-30 | MGNX | 1.59 | 0.18 | 0.29 | 5549 |
| 2025-10-31 | MGNX | 1.655 | 0.21 | 0.03 | 6445 |
| 2025-11-03 | MGNX | 1.575 | 0.20 | 0.00 | 6698 |
| 2025-11-04 | MGNX | 1.44 | 0.21 | 2.67 | 6663 |
| 2025-11-05 | MGNX | 1.43 | 0.20 | 0.82 | 6654 |
| 2025-11-06 | MGNX | 1.36 | 0.21 | 0.00 | 6743 |
| 2025-11-07 | MGNX | 1.36 | 0.21 | 1.00 | 6774 |
| 2025-11-10 | MGNX | 1.425 | 0.21 | 0.00 | 6776 |
| 2025-11-11 | MGNX | 1.515 | 0.21 | 0.00 | 6765 |
| 2025-11-12 | MGNX | 1.475 | 0.20 | 0.00 | 6943 |
| 2025-11-13 | MGNX | 1.59 | 0.20 | 0.00 | 6976 |
| 2025-11-14 | MGNX | 1.5 | 0.20 | 0.01 | 6975 |
| 2025-11-17 | MGNX | 1.52 | 0.20 | 0.12 | 7170 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | MGNX | 1.71 | -136.7 | - | -1.71 |
| 2025-10-21 | MGNX | 2.02 | -136.7 | - | -1.71 |
| 2025-10-22 | MGNX | 1.95 | -136.7 | - | -1.71 |
| 2025-10-23 | MGNX | 1.83 | -136.7 | - | -1.71 |
| 2025-10-24 | MGNX | 1.83 | -136.7 | - | -1.71 |
| 2025-10-27 | MGNX | 1.91 | -136.7 | - | -1.71 |
| 2025-10-28 | MGNX | 1.85 | -136.7 | - | -1.71 |
| 2025-10-29 | MGNX | 1.70 | -136.7 | - | -1.71 |
| 2025-10-30 | MGNX | 1.60 | -136.7 | - | -1.71 |
| 2025-10-31 | MGNX | 1.66 | -136.7 | - | -1.71 |
| 2025-11-03 | MGNX | 1.57 | -136.7 | - | -1.71 |
| 2025-11-04 | MGNX | 1.43 | -136.7 | - | -1.71 |
| 2025-11-05 | MGNX | 1.42 | -136.7 | - | -1.71 |
| 2025-11-06 | MGNX | 1.36 | -136.7 | - | -1.71 |
| 2025-11-07 | MGNX | 1.37 | -136.7 | - | -1.71 |
| 2025-11-10 | MGNX | 1.43 | -136.7 | - | -1.71 |
| 2025-11-11 | MGNX | 1.52 | -136.7 | - | -1.71 |
| 2025-11-12 | MGNX | 1.47 | -136.7 | - | -1.71 |
| 2025-11-13 | MGNX | 1.60 | -136.7 | - | -1.71 |
| 2025-11-14 | MGNX | 1.50 | -136.7 | - | -1.71 |
| 2025-11-17 | MGNX | 1.51 | 81.7 | - | -1.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | MGNX | 1.98 | -7.62 | 6.09 |
| 2025-10-21 | MGNX | 1.98 | -7.62 | 6.09 |
| 2025-10-22 | MGNX | 1.98 | -7.62 | 6.09 |
| 2025-10-23 | MGNX | 1.98 | -7.62 | 6.09 |
| 2025-10-24 | MGNX | 1.98 | -7.62 | 6.09 |
| 2025-10-27 | MGNX | 1.98 | -7.90 | 6.13 |
| 2025-10-28 | MGNX | 1.98 | -7.90 | 6.13 |
| 2025-10-29 | MGNX | 1.97 | -7.90 | 6.13 |
| 2025-10-30 | MGNX | 1.97 | -7.90 | 6.13 |
| 2025-10-31 | MGNX | 1.97 | -7.90 | 6.13 |
| 2025-11-03 | MGNX | 1.98 | -8.28 | 6.13 |
| 2025-11-04 | MGNX | 1.98 | -8.28 | 6.13 |
| 2025-11-05 | MGNX | 1.98 | -8.28 | 6.13 |
| 2025-11-06 | MGNX | 1.98 | -8.28 | 6.13 |
| 2025-11-07 | MGNX | 1.98 | -8.28 | 6.13 |
| 2025-11-10 | MGNX | 1.98 | -7.67 | 6.13 |
| 2025-11-11 | MGNX | 1.98 | -7.67 | 6.13 |
| 2025-11-12 | MGNX | 1.98 | -7.67 | 6.14 |
| 2025-11-13 | MGNX | 1.98 | -7.67 | 6.14 |
| 2025-11-14 | MGNX | 1.98 | -7.67 | 6.13 |
| 2025-11-17 | MGNX | 2.00 | 3.48 | 6.13 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.27
Avg. EPS Est. Current Quarter
-0.15
Avg. EPS Est. Next Quarter
-0.68
Insider Transactions
2
Institutional Transactions
3.48
Beta
1.52
Average Sales Estimate Current Quarter
15
Average Sales Estimate Next Quarter
8
Fair Value
Quality Score
35
Growth Score
29
Sentiment Score
30
Actual DrawDown %
95.9
Max Drawdown 5-Year %
-97
Target Price
3.4
P/E
Forward P/E
PEG
P/S
0.75
P/B
1.43
P/Free Cash Flow
EPS
-1.21
Average EPS Est. Cur. Y
-1.71
EPS Next Y. (Est.)
-2.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-59.46
Relative Volume
1.81
Return on Equity vs Sector %
-140.2
Return on Equity vs Industry %
-125.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading